Swiss National Bank’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.8M Buy
221,300
+13,400
+6% +$291K ﹤0.01% 1325
2025
Q1
$5.04M Sell
207,900
-2,200
-1% -$53.4K ﹤0.01% 1253
2024
Q4
$4.38M Buy
210,100
+2,500
+1% +$52.2K ﹤0.01% 1413
2024
Q3
$4.13M Sell
207,600
-1,200
-0.6% -$23.9K ﹤0.01% 1448
2024
Q2
$3.23M Hold
208,800
﹤0.01% 1549
2024
Q1
$3.33M Buy
208,800
+19,700
+10% +$314K ﹤0.01% 1557
2023
Q4
$3.18M Sell
189,100
-33,400
-15% -$561K ﹤0.01% 1579
2023
Q3
$2.6M Buy
222,500
+4,000
+2% +$46.8K ﹤0.01% 1677
2023
Q2
$2.94M Buy
218,500
+5,100
+2% +$68.5K ﹤0.01% 1637
2023
Q1
$3.54M Sell
213,400
-22,500
-10% -$373K ﹤0.01% 1475
2022
Q4
$4.39M Buy
235,900
+4,200
+2% +$78.1K ﹤0.01% 1400
2022
Q3
$2.97M Hold
231,700
﹤0.01% 1599
2022
Q2
$1.62M Hold
231,700
﹤0.01% 2064
2022
Q1
$1.92M Buy
231,700
+14,300
+7% +$119K ﹤0.01% 2055
2021
Q4
$1.47M Hold
217,400
﹤0.01% 2240
2021
Q3
$1.15M Hold
217,400
﹤0.01% 2366
2021
Q2
$1.25M Sell
217,400
-7,600
-3% -$43.7K ﹤0.01% 2373
2021
Q1
$1.04M Buy
225,000
+5,700
+3% +$26.3K ﹤0.01% 2336
2020
Q4
$732K Hold
219,300
﹤0.01% 2401
2020
Q3
$651K Hold
219,300
﹤0.01% 2289
2020
Q2
$1.01M Buy
219,300
+39,400
+22% +$182K ﹤0.01% 2094
2020
Q1
$693K Buy
179,900
+2,600
+1% +$10K ﹤0.01% 2022
2019
Q4
$665K Buy
177,300
+5,200
+3% +$19.5K ﹤0.01% 2328
2019
Q3
$914K Hold
172,100
﹤0.01% 2105
2019
Q2
$661K Buy
+172,100
New +$661K ﹤0.01% 2324